Pharma

Your Article Summary

See Latest Articles

Watson CFO Mark W. Durand to Take Leave of Absence
Watson Pharmaceuticals, 07/29/09

Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, announced that effective Mark W. Durand, Senior Vice President and Chief Financial Officer, has taken a leave of absence from the Company for health reasons. Paul Bisaro, President and Chief Executive Officer of Watson, announced that R. Todd Joyce, Vice President, Corporate Controller and Treasurer, will serve as Acting Principal Financial Officer, effective immediately.

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09

AHIMA Selects its Leader
HealthDataManagement, 12/14/09

Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09

 See all of Execs on the Move